These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2488177)

  • 1. Beta-2 microglobulin removal during continuous ambulatory peritoneal dialysis (CAPD).
    Lysaght MJ; Pollock CA; Moran JE; Ibels LS; Farrell PC
    Perit Dial Int; 1989; 9(1):29-35. PubMed ID: 2488177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-2 microglobulin in patients on peritoneal dialysis and hemodialysis.
    Scalamogna A; Imbasciati E; De Vecchi A; Castelnovo C; Pagliari B; De Cristofaro V; Ponticelli C
    Perit Dial Int; 1989; 9(1):37-40. PubMed ID: 2488178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal equilibration curve for beta-2-microglobulin (B2M) in CAPD patients.
    Catizone L; Cocchi R; Gagliardini R; Rovinetti C; Fusaroli M; Zucchelli P
    Adv Perit Dial; 1989; 5():200-3. PubMed ID: 2577412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual renal function and volume control in peritoneal dialysis patients.
    Cheng LT; Chen W; Tang W; Wang T
    Nephron Clin Pract; 2006; 104(1):c47-54. PubMed ID: 16741370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small-solute and middle-molecule clearances during continuous flow peritoneal dialysis.
    Leypoldt JK; Burkart JM
    Adv Perit Dial; 2002; 18():26-31. PubMed ID: 12402582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-2 microglobulin amyloidosis in a patient on long-term continuous ambulatory peritoneal dialysis (CAPD).
    Colombi A; Wegmann W
    Perit Dial Int; 1989; 9(4):321-4. PubMed ID: 2535112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 2-microglobulin elimination in end-stage renal disease patients on renal replacement therapy.
    Stefanović V; Kostić S; Djordjević V; Mitić M; Bogicević M
    Perit Dial Int; 1993; 13 Suppl 2():S520-2. PubMed ID: 8399654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
    Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
    Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between plasma beta 2-microglobulin and residual diuresis in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Catizone L; Cocchi R; Fusaroli M; Zucchelli P
    Perit Dial Int; 1993; 13 Suppl 2():S523-6. PubMed ID: 8399655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peritoneal functional parameters after five years on continuous ambulatory peritoneal dialysis (CAPD): the effect of late peritonitis.
    Selgas R; Muñoz J; Cigarran S; Ramos P; L-Revuelta K; Escuin F; Miguel JL
    Perit Dial Int; 1989; 9(4):329-32. PubMed ID: 2577360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clearance of beta-2-microglobulin using continuous ambulatory peritoneal dialysis.
    Sethi D; Murphy CM; Brown EA; Müller BR; Gower PE
    Nephron; 1989; 52(4):352-5. PubMed ID: 2671763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal macrophage beta-2 microglobulin production and bacterial peritonitis in CAPD patients.
    Carozzi S; Nasini G; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
    ASAIO Trans; 1990; 36(3):M369-71. PubMed ID: 2174686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid decline of residual renal function in patients on automated peritoneal dialysis.
    Hiroshige K; Yuu K; Soejima M; Takasugi M; Kuroiwa A
    Perit Dial Int; 1996; 16(3):307-15. PubMed ID: 8761546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 in continuous ambulatory peritoneal dialysis and hemodialysis patients: a preliminary study.
    Lightfoot BO; Caruana RJ
    Perit Dial Int; 1993; 13(1):55-8. PubMed ID: 8443279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urea kinetic analysis of automated peritoneal dialysis allows calculation of a CAPD-equivalent Kt/V(urea).
    Schurman SJ; Shoemaker LR; Warady BA
    Kidney Int; 2000 Sep; 58(3):1318-24. PubMed ID: 10972696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small and middle molecular weight solute clearance in nocturnal intermittent peritoneal dialysis.
    Brophy DF; Sowinski KM; Kraus MA; Moe SM; Klaunig JE; Mueller BA
    Perit Dial Int; 1999; 19(6):534-9. PubMed ID: 10641773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal solute clearances after four years of continuous ambulatory peritoneal dialysis (CAPD).
    Park MS; Lee J; Lee MS; Baick SH; Hwang SD; Lee HB
    Perit Dial Int; 1989; 9(1):75-8. PubMed ID: 2488188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.